Safety of resuming biologic DMARDs in patients who develop tuberculosis after anti-TNF treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety of resuming biologic DMARDs in patients who develop tuberculosis after anti-TNF treatment

Published:2017-08 Issue:1 Volume:47 Page:102-107
ISSN:0049-0172
Container-title:Seminars in Arthritis and Rheumatism
language:en
Short-container-title:Seminars in Arthritis and Rheumatism

Author:

Cho Soo-Kyung,Kim Dam,Won Soyoung,Han Minkyung,Lee Jiyoung,Jang Eun Jin,Kim Tae-Hyung,Bae Sang-Cheol,Sung Yoon-Kyoung

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Rheumatology

Reference30 articles.

1. Tumour necrosis factor antagonists: structure, function, and tuberculosis risks;Walls;Lancet Infect Dis,2008

2. Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy the three-year prospective French research Axed on tolerance of biotherapies registry;Tubach;Arthritis Rheum,2009

3. Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR);Dixon;Ann Rheum Dis,2010

4. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report;Gomez-Reino;Arthritis Rheum,2003

5. Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden;Askling;Arthritis Rheum,2005

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. (Re-)introduction of TNF antagonists and JAK inhibitors in patients with previous tuberculosis: a systematic review;Clinical Microbiology and Infection;2024-08

2. A narrative review of the comparative safety of disease-modifying anti-rheumatic drugs used for the treatment of rheumatoid arthritis;Expert Opinion on Drug Safety;2024-05-23

3. Incidence, risk factors for active tuberculosis infection and changes of IGRA in patients with Takayasu arteritis: a prospective cohort study;Emerging Microbes & Infections;2024-01-22

4. Resuming anti-TNF therapy after development of miliary tuberculosis in Behcet’s disease-related uveitis: a case report;Journal of Ophthalmic Inflammation and Infection;2023-11-28

5. Chapitre 10: Le traitement de la tuberculose active chez les populations particulières;Canadian Journal of Respiratory, Critical Care, and Sleep Medicine;2023-11-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3